Morgan Stanley Maintains Overweight on Everpure, Raises Price Target to $137

Morgan Stanley analyst Benjamin Swinburne has maintained an Overweight rating on Everpure (NYSE: P) and increased the price target from $119 to $137. This adjustment reflects a positive outlook for the company's performance in the market.